Our patient community has been up in arms for quite some time about glucose meter accuracy, or rather lack thereof. Fortunately, the patient-initiated StripSafely campaign seems to have struck a chord, and the FDA has recently — at long last — issued new “draft guidance” on accuracy standards. What surprised a lot of people, though, is how FDA chose to split their recommendations into two categories: one set of requirements for meters purchased over-the-counter and…Read more »
The start of a new year is a time when many of us in the Diabetes Community get especially curious about what latest and greatest new tech tools we’ll be able to get our hands on soon. It’s never easy to get straight answers on this, when you’re relying on company execs, sales and PR people, and regulatory officials who can’t talk specifics or make guarantees.
But we did see a lot of exciting diabetes…
Those of you who read our weekly Ask D’Mine column know what a skeptic Wil Dubois is. We can’t help loving him for it! He’s also one of our devoted editorial team members, so keep that all in mind as you read his take on the 2013 DiabetesMine Innovation Summit that he too attended in Palo Alto, CA, on Nov. 15.
A female pal of mine once told me she’s on an eternal quest for…Read more »
September, this final month of summer-turned-autumn, was a busy one for our Diabetes Online Community, and it brought out some truly great posts and advocacy initiatives from all corners.
Below, in no particular order, is our “Fall Collection” of September posts:
StripSafely is more than the clever name of a grassroots patient advocacy campaign pushing for better glucose monitoring accuracy. It’s also the theme addressed at the big Diabetes Technology Society meeting on Sept.…
You may have heard about the BIG diabetes tech meeting this Monday, tackling the issue of uncertain glucose meter and test strip accuracy and what we might do to improve it.
This day-long meeting held by the Diabetes Technology Society was the second of its kind in four months, and organizers describe it as a “landmark” gathering that brought several hundred diabetes leaders and advocates together from academia, industry, patient groups, and the regulatory sector.…